Induction therapy for locally advanced thymoma Journal Article


Authors: Riely, G. J.; Huang, J.
Article Title: Induction therapy for locally advanced thymoma
Abstract: Thymomas are the most frequently encountered tumors of the mediastinum and often present with either localized or locally advanced disease. The prognosis in thymoma has been consistently shown to correspond to the invasiveness of the tumor (as represented by the Masaoka stage of the tumor) and the completeness of surgical resection. Because treatment with a variety of different chemotherapy regimens has demonstrated radiographic response rates greater than 50% in patients with advanced thymoma, a number of investigators have explored the use of preoperative (induction, neoadjuvant) therapy for patients with locally advanced thymoma. In this review, we summarize the published experience with preoperative therapy for thymoma and discuss ongoing clinical trials exploring multimodality therapy for treatment of locally advanced thymoma. © 2010 by the International Association for the Study of Lung Cancer.
Keywords: cancer surgery; prednisone; review; cisplatin; doxorubicin; advanced cancer; cancer combination chemotherapy; clinical trials as topic; adjuvant therapy; cancer radiotherapy; combined modality therapy; chemotherapy; etoposide; epidermal growth factor receptor; cyclophosphamide; vincristine; cancer invasion; remission induction; epirubicin; thymoma; thymic carcinoma; thymus neoplasms
Journal Title: Journal of Thoracic Oncology
Volume: 5
Issue: 10 Suppl. 4
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2010-10-01
Start Page: S323
End Page: S326
Language: English
DOI: 10.1097/JTO.0b013e3181f20e90
PUBMED: 20859127
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 20 April 2011" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. James Huang
    214 Huang
  2. Gregory J Riely
    599 Riely